The use of anabolic-androgenic steroids in sport and the preventive role of the pharmacist by Galea, James
THE USE OF ANABOLIC-ANDROGENIC 
STEROIDS IN SPORT AND THE PREVENTIVE 
ROLE OF THE PHARMACIST 
James Galea 
Anabolic Steroids (AS) as Doping Agents 
The use of chemical substances to enhance physical activity is not a 
contemporary phenomenon; it goes back thousands of years. However, it 
has increased to alarming proportions in the last four decades and has 
created a serious problem in the world of sport, spreading many 
ramifications (Donohoe and Johnson, 1986). A broad array of 
pharmacological agents are employed to enhance athletic performance 
(Le. doping). The most notorious of these drugs have been anabolic-
androgenic steroids (AS). Abuse of AS by athletes constitutes just one 
aspect of doping of athletes (Wilson, 1988). 
AS are a group of synthetic steroid compounds that are structurally 
related to the natural male sex hormone testosterone (Murad and Haynes, 
1985). Testosterone was isolated in 1935 and its metabolic effects 
elucidated shortly after. In 1939, Boje suggested that the use of male sex 
hormones might enhance athletic performance (Yesalis, et al. 1989). 
With the abrupt closure of the 1950s, an astounded world learned of 
widespread use of AS by weightlifters and bodybuilders (Wilson, 1988). 
Their use escalated over the following decades and culminated in the 
drug scandals of the 1988 Seoul Olympics. AS have permeated a myraid 
of sports, including endurance events. Even more disturbing however, is 
the fact that the use of these drugs is not limited solely to elite athletes, 
but has trickled down to the recreational and non-competitive athlete 
aspiring to increase his muscular strength and size and improving his 
appearance (Wright, 1980). This craze for AS as a potential short-cut to 
athletic achievement, has been created predominantly by our society's 
heavy emphasis on winning, appearance and quick results (Klein and 
Knapp, 1989). 
Many athletes perceive a competitive edge in the use of these drugs. 
However, any reported benefits for the athlete are tempered by potential 
deleterious effects on health (Kibble and Ross, 1987). The level of fair 
play, a key issue· in sport and the adverse effects of AS (especially the 
largely unstudied long term effects) are two worrying problems stemming 
from the non-medical use of AS (Yesalis, et al. 1989). 
Survey on AS use among Male Maltese Bodybuilders and Weightlifters 
Rumour of extensive non-medical use of AS by specific categories of local 
athletes, abounds. However, the prevalence of use of these drugs within 
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the Maltese athletic sphere, has never been documented by using 
appropriate epidemiological methods. 
Therefore, in addition to detailing the various aspects of AS and their 
controversial use as ergogenics in sport, this study also attempted to 
provide a clear picture of the situation in Malta and to identify the 
prevalence of AS use among two categories of Maltese athletes. These 
were male amateur and recreational bodybuilders and weightlifters. 
During September, 1991, (prior to two local bodybuilding 
championships), a questionnaire was mailed directly to the athletes 
making up the study population. This was taken from nine fitness centres 
around Malta. The athletes had to be engaged in serious training to 
qualify for participation in the survey. Anonymity was guaranteed. The 
participants were provided with self-addressed envelopes in which to 
return the self-completed questionnaire. 
Results of the Survey 
The overall participation rate was 53% (n=115). The study revealed 
several interesting points, SOME of which are summarized in Figures 1-4 
and Tables 1-3. 
Table 1: General results of the survr~y 
Potential Participants 
Total responders 
Overall participation rate 
Prevalence of AS use (see Fig. 1) 
Non-users and against AS 
Potential future users 
Previous AS users 
Users at time of survey 
% 
53.0 
52.2 
15.7 
183 
13.9 
Mean Age of study population: 24 years (Range: 15-46 years) 
N 
217 
115 
115 
60 
18 
21 
16 
Mean training years of study population - 4.54 years (Range: 6 months -
25 years) 
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Table 2: Some characteristics and perceptions of the study population as 
a whole (n=115) 
Non-Users Potential AS users 
52.2% Future users 32.2% 
(n=60) 15.7% (n=18) (n=37) 
% n % n % n 
Aware of drugs called 
anabolic steroids 100.0 60 100.0 18 100.0 37 
Had a close friend 
using AS 
Yes 31.7 19 61.1 11 83.8 31 
No 68.3 41 38.9 7 8.1 3 
Not revealed 8.1 3 
Aware of potential 
side effects of AS 
Yes 96.7 58 83.3 15 81.1 30 
No 3.3 2 16.7 3 8.1 3 
Not revealed 10.8 4 
AS perceived as 
indispensable to 
athletic success 
Yes 45 27 77.8 4 78.4 29 
No 53.3 32 16.7 3 16.2 6 
Not revealed 1.7 1 5.6 1 5.4 2 
Consultation with 
pharmacist on AS 
*Yes 11.7 7 27.8 5 40.5 15 
No 88.3 53 72.2 13 54.1 20 
Not revealed 5.4 2 
*Pharmacist consulted 
and found knowledge-
able about AS 
Yes 57.1 4 80 4 13.3 2 
No 42.9 3 20 1 86.7 13 
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Table 3: Some aspects of AS among the athletes using these drugs 
(n=37) 
AS users (n=37) 
% n 
Age at which AS use was initiated (Fig. 2) 
::;; 20 years 16.2 6 
21-25 years 40.5 15 
26-30 18.9 7 
;::: 31 years 18.9 7 
Not revealed 5.4 2 
Combination of motives for using AS (Fig. 3) 
Increased strength/harder training 86.5 32 
Competition 45.9 17 
Appearance /Self-confidence 24.3 9 
Not revealed 5.4 2 
Combination of AS sources (Fig. 4) 
Gyms 48.6 18 
Community pharmacies 29.7 11 
Foreign sources 21.6 8 
Government pharmacies 13.5 5 
Black market 13.5 5 
Not revealed 16.2 6 
Convinced that AS enhance athletic performance 
y~s 94.6 35 
No 
Not revealed 5.4 2 
53 
Fig 1. Prevalence of anabolic steroid (AS) use 
by male Maltese bodybuilders and weightlifters 
18.3% (n = 21) 
Previous AS users 
52.2% (n = 60) 
_---;...;N..;.on;.;.-..:.;.users and against AS 
13.9% (n =16) 
Current AS users at 
the time of the survey 
Potential future 
AS users 
Fig 2. Age when anabolic steroid use was initiated 
not revealed 
5.41% 
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Completing the picture: personal interviews with the athletes and other 
persons concerned about this problem in Malta 
Personal interviews with the above (including three foreign bodybuilders 
who were in Malta during that time), revealed other interesting points 
and clarified aspects of AS as revealed by the survey, including: 
a. The fact that AS have been used by Maltese athletes since the late 
1960s. 
b. The 'cycling' and 'stacking' regimens of AS administration and the 
use of excessively high dosages of these drugs. Cycles of AS may 
extend anywhere from 4-18 weeks, with 'drug-holidays' of varying 
lengths. Some athletes were consuming an average of 92mg and 
154mg weekly of oral and parenteral AS respectively, over a 
period of thirteen weeks. 
c. The practice of 'polypharmacy' by some athletes. In addition to 
AS, some athletes were using mesterelone (Pro-VironR), tamoxifen 
(NolvadexR) and human chorionic gonadotrophin/HCG (ProfasiR) 
hoping to offset side effects of AS and a host of other drugs 
(including diuretics, appetite suppressants and thyroxine tablets to 
increase muscular definition) and also excessive dietary 
supplementation. 
d. A thriving underground network, with AS being sold at exorbitant 
prices. An athlete embarking on a drug cycle of 13 weeks is 
expected to spend anywhere from Lm150-Lm250 ($470-$790) as AS 
AT,ONF.. Thprp arp also TPasons to ciOllbt thE' qnality of these illicit 
AS preparations. The stark reality is that athletes who believe 
that drugs make their sporting ambition come true, will do 
everything to obtain such preparations. 
Conclusions and Recommendations 
The need for a nationwide anti-doping campaign in Malta 
The results of the study indicate the acute need for appropriate 
prevention and intervention policies to curb doping in Malta. There has 
been some sporadic attempts by individual bodies in the past, to curtail 
. this problem, locally. However, these attempts have yielded poor 
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results because the essential components of an effective anti-doping 
campaign were not entirely utilised and because little was known about 
the problem. 
Practical solutions to the problem as adopted by foreign countries are 
examined to ensure accuracy and clarity relevant to the local needs. A 
plan of action is outlined. This entails the setting up of a Central Anti-
Doping Agency (CADA) to develop and implement an appropriate anti-
doping programme in Malta. Initially, this central body should evaluate 
thoroughly the extent of doping in Malta through proper 
epidemiological methods. The factual information obtained during these 
preliminary stages dictates the anti-doping strategy. This need has been 
outlined to the appropriate body and positive action seems very 
promising. 
Potential solutions to this problem lie in anti-doping legislation and 
administrative measures, drug testing and punitive measures on doping 
offences, drug education, intervention and treatment of athletes with a 
drug problem and provision of positive alternatives to drugs in sports. 
Sport inevitably reflects the character of the society in which it is found. 
Doping in sport presents a challenge to society as a whole. Therefore, 
close cooperation and collaboration between the central anti-doping body 
and local organisations responsible for health, justice, culture and sport, 
as well as other local resources are a prerequisite for an effective anti-
doping campaign. 
The role of the Pharmacist in this sphere 
Though sports pharmacy is a relatively new area, a ray of light may 
break through with the preventive role of the pharmacist in the use of 
AS and other illicit drug aids by athletes. Education, information 
retrieval and interpretation, drug testing, legislation, research and 
evaluation (Wagner, 1989) are potential routes for the pharmacist in 
his/her search for better implementation of health care in an athletic 
setting. 
The old adage runs that prevention is better than cure. This is the golden 
rule to open wide the doors of this "scrooge" in sport. Preventive drug 
education and awareness programmes are the cornerstones in the struggle 
against drug misuse and abuse in sport and society in general (Isetts, 1989). 
However, emphasis must be laid on the diffusion of the right information 
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and the proper medium to reach the whole spectrum of the audience. 
Otherwise, half truths or the wrong information may lead some 
individuals to experiment with these chemicals and spoil the original 
purpose of drug education (Goldberg, 1991). 
Therefore, in addition to factual drug information, an appropriate drug 
educational campaign should consider the development of attitudes and 
behavio]lrs, such as building-up self-esteem, promoting decision-making 
and assetion skills and stress reduction (Tricker, 1990). More emphasis on 
alternative recreational options and education on better use of one's 
leisure time are also desirable. An educational approach should be a long 
term process. Greater mutual respect and trust between athletes and 
health care professionals is also expected. An educational pamphlet on 
AS for athletes is a priority on the researcher's agenda. 
In addition to being health educators, pharmacists keen on sport and its 
pharmaceutical aspects can help athletes and coaches in revising their 
approach to athletic preparation. 
In turn the pharmacist has to be wise enough to suggest ways how to 
avoid the use of ergogenic drugs. The pharmacist can help in this 
direction by encouraging athletes to seek safe and positive alternatives to 
drugs, including appropriate nutrition and training methodology, a 
reliable coach and development of psychological skills (e.g. mental 
rehearsal of events, positive self-talk, relaxation techniques) (Hemery, 
1990). 
A research agenda on doping and AS is also offered for possible future 
TPfpTPnC'P. 
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